Ambit Biosciences Corp
AMBI
AMBI was delisted on the 10th of November, 2014.
23 hedge funds and large institutions have $76M invested in Ambit Biosciences Corp in 2013 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 6 closing their positions.
150% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 6
106% more capital invested
Capital invested by funds: $36.9M → $76M (+$39.1M)
53% more funds holding
Funds holding: 15 → 23 (+8)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$1.34M |
| 2 |
EI
EAM Investors
Solana Beach,
California
|
+$1.32M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$517K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$343K |
| 5 |
SIM
Spark Investment Management
New York
|
+$321K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$1.53M |
| 2 |
PRCM
Pine River Capital Management
Minnetonka,
Minnesota
|
-$1.22M |
| 3 |
Alyeska Investment Group
Chicago,
Illinois
|
-$525K |
| 4 |
FM
Forward Management
San Francisco,
California
|
-$429K |
| 5 |
WC
Wexford Capital
West Palm Beach,
Florida
|
-$321K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Goldman Sachs
New York
| – | -$184K | -26,297 | Closed |
|
|
SIP
27
Stoneridge Investment Partners
Radnor,
Pennsylvania
| – | -$153K | -21,906 | Closed |
|
28
Citigroup
New York
| – | -$1K | -150 | Closed |
|
AMBI Hedge Fund Activity: Q3 2013 in Review
23 of the 3,085 institutional investors tracked by Wall St. Rank reported a position in Ambit Biosciences Corp (AMBI) for Q3 2013, worth a combined $76M — up 106% from $36.9M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new AMBI positions and 6 closed out — a net gain of 9 holders — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $1.34M. The largest seller was JP Morgan Chase, exiting entirely with an estimated $1.53M sold.
- 23 institutional investors held Ambit Biosciences Corp (AMBI) as of Q3 2013, up from 15 in Q2 2013.
- Funds reported $76M of Ambit Biosciences Corp stock for Q3 2013, up 106% quarter-over-quarter.
- 15 funds opened new Ambit Biosciences Corp positions in Q3 2013 and 6 closed out, a net change of +9 holders.
- The largest Ambit Biosciences Corp buyer in Q3 2013 was Millennium Management, an estimated $1.34M added.
- The largest Ambit Biosciences Corp seller in Q3 2013 was JP Morgan Chase, an estimated $1.53M sold.
Based on aggregated 13F filings for Q3 2013.